Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer

Erdem Cubukcu; Omer Fatih Olmez; Ozkan Kanat; Selva Kabul; Mustafa Canhoroz; Nilufer Avci; Mustafa Hartavi; Adem Deligonul; Sinem Çubukçu; Osman Manavoglu

doi:10.5114/wo.2014.40454

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2014
vol. 18

Send email

Copy url:

abstract:

Original paper

Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer

Erdem Cubukcu

,

Omer Fatih Olmez

,

Ozkan Kanat

,

Selva Kabul

,

Mustafa Canhoroz

,

Nilufer Avci

,

Mustafa Hartavi

,

Adem Deligonul

,

Sinem Çubukçu

,

Osman Manavoglu

Contemp Oncol (Pozn) 2014; 18 (1): 34–38

DOI: https://doi.org/10.5114/wo.2014.40454

Online publish date: 2014/02/28

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Cubukcu E, Olmez O, Kanat O, et al. Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer. Contemporary Oncology/Współczesna Onkologia. 2014;18(1):34-38. doi:10.5114/wo.2014.40454.

APA

Cubukcu, E., Olmez, O., Kanat, O., Kabul, S., Canhoroz, M.,  & Avci, N. et al. (2014). Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer. Contemporary Oncology/Współczesna Onkologia, 18(1), 34-38. https://doi.org/10.5114/wo.2014.40454

Chicago

Cubukcu, Erdem, Omer Fatih Olmez, Ozkan Kanat, Selva Kabul, Mustafa Canhoroz, Nilufer Avci,  and Mustafa Hartavi et al. 2014. "Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer". Contemporary Oncology/Współczesna Onkologia 18 (1): 34-38. doi:10.5114/wo.2014.40454.

Harvard

Cubukcu, E., Olmez, O., Kanat, O., Kabul, S., Canhoroz, M., Avci, N., Hartavi, M., Deligonul, A., Çubukçu, S.,  and Manavoglu, O. (2014). Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer. Contemporary Oncology/Współczesna Onkologia, 18(1), pp.34-38. https://doi.org/10.5114/wo.2014.40454

MLA

Cubukcu, Erdem et al. "Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer." Contemporary Oncology/Współczesna Onkologia, vol. 18, no. 1, 2014, pp. 34-38. doi:10.5114/wo.2014.40454.

Vancouver

Cubukcu E, Olmez O, Kanat O, Kabul S, Canhoroz M, Avci N et al. Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer. Contemporary Oncology/Współczesna Onkologia. 2014;18(1):34-38. doi:10.5114/wo.2014.40454.

PlumX metrics:

Introduction: Triple-negative breast cancers (TNBCs) – which lack the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) – have no established markers that can be used for prognostic stratification. As adiponectin has been previously implicated in a more aggressive phenotype of primary bre-ast cancer, we explored the relation between adiponectin immunohistochemical expression and prognosis in TNBCs.

Material and methods: Immunohistochemical staining for adiponectin was performed in 38 TNBC patients. Disease-free survival (DFS) and overall survival (OS) served as the main outcome measures.

Results: Of the 38 TNBC patients, 18 (47%) had negative and 20 (53%) positive adiponectin immunohistochemical expression. We did not find any significant association between adiponectin immunohistochemical expression and the baseline characteristics. In addition, there were no associations between adiponectin immunohistochemical expression and prognosis.

Conclusions: Although our results suggest that adiponectin immunohistochemical expression is not of prognostic significance in TNBCs, further studies are warranted to determine the role of this adipokine in breast cancer biology.

keywords:

Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer

Erdem Cubukcu , Omer Fatih Olmez , Ozkan Kanat , Selva Kabul , Mustafa Canhoroz , Nilufer Avci , Mustafa Hartavi , Adem Deligonul , Sinem Çubukçu , Osman Manavoglu

triple-negative breast cancer, adiponectin, immunohistochemistry, prognosis

Erdem Cubukcu

,

Omer Fatih Olmez

,

Ozkan Kanat

,

Selva Kabul

,

Mustafa Canhoroz

,

Nilufer Avci

,

Mustafa Hartavi

,

Adem Deligonul

,

Sinem Çubukçu

,

Osman Manavoglu